A citation-based method for searching scientific literature

Yoshie Yoshikawa, Ayuko Sato, Tohru Tsujimura, Mitsuru Emi, Tomonori Morinaga, Kazuya Fukuoka, Shusai Yamada, Aki Murakami, Nobuyuki Kondo, Seiji Matsumoto, Yoshitomo Okumura, Fumihiro Tanaka, Seiki Hasegawa, Takashi Nakano, Tomoko Hashimoto-Tamaoki. Cancer Sci 2012
Times Cited: 124







List of co-cited articles
773 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Germline BAP1 mutations predispose to malignant mesothelioma.
Joseph R Testa, Mitchell Cheung, Jianming Pei, Jennifer E Below, Yinfei Tan, Eleonora Sementino, Nancy J Cox, A Umran Dogan, Harvey I Pass, Sandra Trusa,[...]. Nat Genet 2011
634
69

The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma.
Matthew Bott, Marie Brevet, Barry S Taylor, Shigeki Shimizu, Tatsuo Ito, Lu Wang, Jenette Creaney, Richard A Lake, Maureen F Zakowski, Boris Reva,[...]. Nat Genet 2011
461
68

High Incidence of Somatic BAP1 alterations in sporadic malignant mesothelioma.
Masaki Nasu, Mitsuru Emi, Sandra Pastorino, Mika Tanji, Amy Powers, Hugh Luk, Francine Baumann, Yu-An Zhang, Adi Gazdar, Shreya Kanodia,[...]. J Thorac Oncol 2015
189
49

BAP1 and cancer.
Michele Carbone, Haining Yang, Harvey I Pass, Thomas Krausz, Joseph R Testa, Giovanni Gaudino. Nat Rev Cancer 2013
388
32

BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations.
Marta Cigognetti, Silvia Lonardi, Simona Fisogni, Piera Balzarini, Vilma Pellegrini, Andrea Tironi, Luisa Bercich, Mattia Bugatti, Giulio Rossi, Bruno Murer,[...]. Mod Pathol 2015
152
32

Germline mutations in BAP1 predispose to melanocytic tumors.
Thomas Wiesner, Anna C Obenauf, Rajmohan Murali, Isabella Fried, Klaus G Griewank, Peter Ulz, Christian Windpassinger, Werner Wackernagel, Shea Loy, Ingrid Wolf,[...]. Nat Genet 2011
467
28

Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma.
Guangwu Guo, Juliann Chmielecki, Chandra Goparaju, Adriana Heguy, Igor Dolgalev, Michele Carbone, Sara Seepo, Matthew Meyerson, Harvey I Pass. Cancer Res 2015
196
28

Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations.
Raphael Bueno, Eric W Stawiski, Leonard D Goldstein, Steffen Durinck, Assunta De Rienzo, Zora Modrusan, Florian Gnad, Thong T Nguyen, Bijay S Jaiswal, Lucian R Chirieac,[...]. Nat Genet 2016
455
27

BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs.
Michele Carbone, Laura Korb Ferris, Francine Baumann, Andrea Napolitano, Christopher A Lum, Erin G Flores, Giovanni Gaudino, Amy Powers, Peter Bryant-Greenwood, Thomas Krausz,[...]. J Transl Med 2012
193
26

Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers.
Mohamed H Abdel-Rahman, Robert Pilarski, Colleen M Cebulla, James B Massengill, Benjamin N Christopher, Getachew Boru, Peter Hovland, Frederick H Davidorf. J Med Genet 2011
302
25

Frequent mutation of BAP1 in metastasizing uveal melanomas.
J William Harbour, Michael D Onken, Elisha D O Roberson, Shenghui Duan, Li Cao, Lori A Worley, M Laurin Council, Katie A Matatall, Cynthia Helms, Anne M Bowcock. Science 2010
894
25

Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study.
Marco Lo Iacono, Valentina Monica, Luisella Righi, Federica Grosso, Roberta Libener, Simona Vatrano, Paolo Bironzo, Silvia Novello, Loredana Musmeci, Marco Volante,[...]. J Thorac Oncol 2015
98
25

Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group.
Aliya N Husain, Thomas Colby, Nelson Ordonez, Thomas Krausz, Richard Attanoos, Mary Beth Beasley, Alain C Borczuk, Kelly Butnor, Philip T Cagle, Lucian R Chirieac,[...]. Arch Pathol Lab Med 2013
299
25

BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations.
Brandon S Sheffield, Harry C Hwang, Anna F Lee, Kim Thompson, Stephanie Rodriguez, Christopher H Tse, Allen M Gown, Andrew Churg. Am J Surg Pathol 2015
112
25

Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival.
Francine Baumann, Erin Flores, Andrea Napolitano, Shreya Kanodia, Emanuela Taioli, Harvey Pass, Haining Yang, Michele Carbone. Carcinogenesis 2015
140
25

Loss of expression of BAP1 predicts longer survival in mesothelioma.
Mahtab Farzin, Christopher W Toon, Adele Clarkson, Loretta Sioson, Nicole Watson, Juliana Andrici, Anthony J Gill. Pathology 2015
77
31

Clinical characteristics of patients with malignant pleural mesothelioma harboring somatic BAP1 mutations.
Marjorie G Zauderer, Matthew Bott, Robert McMillan, Camelia S Sima, Valerie Rusch, Lee M Krug, Marc Ladanyi. J Thorac Oncol 2013
55
40

Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma.
Jinfei Xu, Yuwaraj Kadariya, Mitchell Cheung, Jianming Pei, Jacqueline Talarchek, Eleonora Sementino, Yinfei Tan, Craig W Menges, Kathy Q Cai, Samuel Litwin,[...]. Cancer Res 2014
89
23

Germline BAP1 mutations predispose to renal cell carcinomas.
Tatiana Popova, Lucie Hebert, Virginie Jacquemin, Sophie Gad, Virginie Caux-Moncoutier, Catherine Dubois-d'Enghien, Bénédicte Richaudeau, Xavier Renaudin, Jason Sellers, André Nicolas,[...]. Am J Hum Genet 2013
181
20

BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma.
Stephanie M McGregor, Ryan Dunning, Elizabeth Hyjek, Wickii Vigneswaran, Aliya N Husain, Thomas Krausz. Hum Pathol 2015
78
25

Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology Specimens.
Harry C Hwang, Brandon S Sheffield, Stephanie Rodriguez, Kim Thompson, Christopher H Tse, Allen M Gown, Andrew Churg. Am J Surg Pathol 2016
99
20

Tumours associated with BAP1 mutations.
Rajmohan Murali, Thomas Wiesner, Richard A Scolyer. Pathology 2013
177
19

BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization.
Karen H Ventii, Narra S Devi, Kenneth L Friedrich, Tatiana A Chernova, Mourad Tighiouart, Erwin G Van Meir, Keith D Wilkinson. Cancer Res 2008
234
19

BAP1 protein is a progression factor in malignant pleural mesothelioma.
Lisa Arzt, Franz Quehenberger, Iris Halbwedl, Thomas Mairinger, Helmut H Popper. Pathol Oncol Res 2014
54
35

BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression.
D E Jensen, M Proctor, S T Marquis, H P Gardner, S I Ha, L A Chodosh, A M Ishov, N Tommerup, H Vissing, Y Sekido,[...]. Oncogene 1998
512
18

New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment.
Marc Ladanyi, Marjorie G Zauderer, Lee M Krug, Tatsuo Ito, Robert McMillan, Matthew Bott, Filippo Giancotti. Clin Cancer Res 2012
55
32

New Markers for Separating Benign From Malignant Mesothelial Proliferations: Are We There Yet?
Andrew Churg, Brandon S Sheffield, Francoise Galateau-Salle. Arch Pathol Lab Med 2016
96
18

Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families.
Ching-Ni Jenny Njauw, Ivana Kim, Adriano Piris, Michele Gabree, Michael Taylor, Anne Marie Lane, Margaret M DeAngelis, Evangelos Gragoudas, Lyn M Duncan, Hensin Tsao. PLoS One 2012
171
17

Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair.
Helen Yu, Helen Pak, Ian Hammond-Martel, Mehdi Ghram, Amélie Rodrigue, Salima Daou, Haithem Barbour, Luc Corbeil, Josée Hébert, Elliot Drobetsky,[...]. Proc Natl Acad Sci U S A 2014
217
17

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.
Nicholas J Vogelzang, James J Rusthoven, James Symanowski, Claude Denham, E Kaukel, Pierre Ruffie, Ulrich Gatzemeier, Michael Boyer, Salih Emri, Christian Manegold,[...]. J Clin Oncol 2003
17

Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas.
Simion Chiosea, Alyssa Krasinskas, Philip T Cagle, Kisha A Mitchell, Dani S Zander, Sanja Dacic. Mod Pathol 2008
139
17

BAP1 loss defines a new class of renal cell carcinoma.
Samuel Peña-Llopis, Silvia Vega-Rubín-de-Celis, Arnold Liao, Nan Leng, Andrea Pavía-Jiménez, Shanshan Wang, Toshinari Yamasaki, Leah Zhrebker, Sharanya Sivanand, Patrick Spence,[...]. Nat Genet 2012
604
16

Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB.
Johanna C Scheuermann, Andrés Gaytán de Ayala Alonso, Katarzyna Oktaba, Nga Ly-Hartig, Robert K McGinty, Sven Fraterman, Matthias Wilm, Tom W Muir, Jürg Müller. Nature 2010
506
16

Malignant mesothelioma: facts, myths, and hypotheses.
Michele Carbone, Bevan H Ly, Ronald F Dodson, Ian Pagano, Paul T Morris, Umran A Dogan, Adi F Gazdar, Harvey I Pass, Haining Yang. J Cell Physiol 2012
233
16

Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology.
Juliana Andrici, Amy Sheen, Loretta Sioson, Kathryn Wardell, Adele Clarkson, Nicole Watson, Mahsa S Ahadi, Mahtab Farzin, Christopher W Toon, Anthony J Gill. Mod Pathol 2015
66
24

Molecular pathogenesis of malignant mesothelioma.
Yoshitaka Sekido. Carcinogenesis 2013
148
15

The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1.
Yuichi J Machida, Yuka Machida, Ajay A Vashisht, James A Wohlschlegel, Anindya Dutta. J Biol Chem 2009
178
15

The diagnostic utility of p16 FISH and GLUT-1 immunohistochemical analysis in mesothelial proliferations.
Sara E Monaco, Yongli Shuai, Mona Bansal, Alyssa M Krasinskas, Sanja Dacic. Am J Clin Pathol 2011
82
18

Diagnostic usefulness of p16/CDKN2A FISH in distinguishing between sarcomatoid mesothelioma and fibrous pleuritis.
Di Wu, Kenzo Hiroshima, Shinji Matsumoto, Kazuki Nabeshima, Toshikazu Yusa, Daisuke Ozaki, Michio Fujino, Hisami Yamakawa, Yukio Nakatani, Yuji Tada,[...]. Am J Clin Pathol 2013
69
21

BAP1 immunohistochemistry and p16 FISH results in combination provide higher confidence in malignant pleural mesothelioma diagnosis: ROC analysis of the two tests.
Tomoyuki Hida, Makoto Hamasaki, Shinji Matsumoto, Ayuko Sato, Tohru Tsujimura, Kunimitsu Kawahara, Akinori Iwasaki, Tatsuro Okamoto, Yoshinao Oda, Hiroshi Honda,[...]. Pathol Int 2016
52
28

Germline BAP1 mutations predispose also to multiple basal cell carcinomas.
A de la Fouchardière, O Cabaret, L Savin, P Combemale, H Schvartz, C Penet, V Bonadona, N Soufir, B Bressac-de Paillerets. Clin Genet 2015
68
20

The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression.
Helen Yu, Nazar Mashtalir, Salima Daou, Ian Hammond-Martel, Julie Ross, Guangchao Sui, Gerald W Hart, Frank J Rauscher, Elliot Drobetsky, Eric Milot,[...]. Mol Cell Biol 2010
177
14


Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer.
Y Sekido, H I Pass, S Bader, D J Mew, M F Christman, A F Gazdar, J D Minna. Cancer Res 1995
230
13

High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas.
A B Bianchi, S I Mitsunaga, J Q Cheng, W M Klein, S C Jhanwar, B Seizinger, N Kley, A J Klein-Szanto, J R Testa. Proc Natl Acad Sci U S A 1995
252
13

Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O.
Nazar Mashtalir, Salima Daou, Haithem Barbour, Nadine N Sen, Jessica Gagnon, Ian Hammond-Martel, Haider H Dar, Marc Therrien, El Bachir Affar. Mol Cell 2014
111
13

Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area.
Marta Betti, Elisabetta Casalone, Daniela Ferrante, Antonio Romanelli, Federica Grosso, Simonetta Guarrera, Luisella Righi, Simona Vatrano, Giuseppe Pelosi, Roberta Libener,[...]. Genes Chromosomes Cancer 2015
43
30

Loss of BAP1 function leads to EZH2-dependent transformation.
Lindsay M LaFave, Wendy Béguelin, Richard Koche, Matt Teater, Barbara Spitzer, Alan Chramiec, Efthymia Papalexi, Matthew D Keller, Todd Hricik, Katerina Konstantinoff,[...]. Nat Med 2015
208
13

Integrative Molecular Characterization of Malignant Pleural Mesothelioma.
Julija Hmeljak, Francisco Sanchez-Vega, Katherine A Hoadley, Juliann Shih, Chip Stewart, David Heiman, Patrick Tarpey, Ludmila Danilova, Esther Drill, Ewan A Gibb,[...]. Cancer Discov 2018
258
13

Germline mutations in BAP1 impair its function in DNA double-strand break repair.
Ismail Hassan Ismail, Riley Davidson, Jean-Philippe Gagné, Zhi Zhong Xu, Guy G Poirier, Michael J Hendzel. Cancer Res 2014
125
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.